CJC-1295 + Ipamorelin
GHRH and GHRP combination studied for pulsatile growth hormone release.
Therapies that may influence sleep architecture and restorative rest.
GHRH and GHRP combination studied for pulsatile growth hormone release.
Coenzyme central to cellular energy, sirtuin activation, and DNA-repair pathways.
Immunomodulatory peptide studied for T-cell function.
GHRH analog studied for stimulation of the body's own growth hormone.
Orally active ghrelin receptor agonist studied for GH/IGF-1 secretion.
Peptide fragment studied primarily in preclinical models for tissue repair.
Mitochondrial-derived peptide studied in metabolic homeostasis research.
Endogenous tripeptide antioxidant used clinically in select settings.
Tetrapeptide studied for telomerase activity and circadian rhythm.
A branded compounded blend combining BPC-157 and TB-500, two research peptides individually studied in preclinical models for tissue repair. Neither component is FDA-approved; this specific combination has not been evaluated in clinical trials as a combination.